Kodiak Sciences Inc (NAS:KOD)
$ 3.61 -0.19 (-5%) Market Cap: 189.65 Mil Enterprise Value: -4.24 Mil PE Ratio: 0 PB Ratio: 0.71 GF Score: 41/100

Kodiak Sciences Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript

May 13, 2020 / 06:20PM GMT
Release Date Price: $53.67 (-3.66%)
Tazeen Ahmad
BofA Merrill Lynch, Research Division - VP

Good afternoon. Welcome to the Bank of America Health Care Conference. I am Tazeen Ahmad, one of the senior biotech analysts here at the firm. It is my pleasure to have our next presenting company, Kodiak Sciences. Presenting today for Kodiak is Chief Executive Officer, Victor Perlroth. Hi, Victor.

Victor Perlroth
Kodiak Sciences Inc. - Co-Founder, Chairman, CEO & President

Hello.

Tazeen Ahmad
BofA Merrill Lynch, Research Division - VP

I think you have a slide deck uploaded. So I will let you take it from here and give us an overview of Kodiak.

Victor Perlroth
Kodiak Sciences Inc. - Co-Founder, Chairman, CEO & President

Thank you. Thank you very much. I have together with me, Jason Ehrlich, our Chief Medical and Development Officer; and also John Borgeson, our Chief Financial Officer, as needed if we have time for questions. Thank you so much for the opportunity.

Just move quickly into our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot